Sponsored Links
| ZALTRAP™ (Aflibercept) Significantly Improved Survival In Previously Treated Metastatic Colorectal Cancer Patients |
 |
 |
 |
| Medical News - Colorectal Cancer | |||
|
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that data showing that the investigational agent ZALTRAP™ (aflibercept), also known as VEGF Trap, significantly improved survival in previously treated metastatic colorectal cancer patients will be presented at the ESMO World Congress on Gastrointestinal Cancer on June 25, 2011... Read more: Colorectal Cancer News From Medical News Today
|